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Purpose: To use magnetic resonance (MR) imaging to document 
the appearance of perianal infection in patients with a 
hematologic malignancy (HM) compared with that in im-
munocompetent control patients.
Materials and 
Methods:
After an ethical waiver was obtained, 38 patients with 
an HM were matched by age and sex to 38 control pa-
tients with no history of immunocompromise or Crohn 
disease. Both groups had undergone MR imaging for peri-
anal symptoms and/or systemic sepsis. Two radiologists 
who were blinded to the diagnosis independently reviewed 
the MR images and recorded the size and distribution 
of abscesses and/or fistula tracts, the extent of perianal 
edema, and the likely diagnosis. Groups were compared 
by using the Mann-Whitney-Wilcoxon, x2, or Fisher exact 
test. Receiver operating characteristic (ROC) curves were 
constructed to estimate the ability of MR imaging to help 
distinguish patients with an HM from control patients.
Results: Patients with an HM had significantly greater perianal 
edema than did control patients (mean arc angle of anal 
canal involved, 220° vs 60°; P , .001). However, they 
had significantly lower rates of fistula (15 [39.5%] vs 
35 [92.1%] of 38; P , .001). Abscesses were similar in 
frequency (10 [26.3%] vs 17 [44.7%] of 38; P = .15) and 
were unrelated to the degree of neutropenia (P = .71) or 
the use of chemotherapy (P = .10). Surgical treatment 
was rarely required in patients with an HM, either during 
the acute illness (four [10.5%] of 38) or thereafter (three 
[7.9%] of 38). MR imaging had an excellent ability to help 
discriminate patients with HM from immunocompetent 
patients (areas under the ROC curve, 0.91 and 0.97).
Conclusion: Perianal infection in patients with an HM is more likely to 
cause diffuse perianal edema and is less likely to cause fis-
tulas than in immunocompetent patients. MR imaging can 
help distinguish patients with an HM from those without 
immunocompromise.
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Hematologic malignancies account for almost 10% of new cancer diagnoses annually in the United 
States (1) and represent abnormal pro-
liferation of hematopoietic or lymphoid 
cell lines (2). Patients with these ma-
lignancies are immunocompromised 
because of the clonal expansion of ma-
lignant cells in the bone marrow that 
disrupts normal immunologic function. 
Furthermore, treatment for hemato-
logic malignancies is commonly immu-
nosuppressive, whether through che-
motherapy or marrow irradiation or 
after bone marrow transplantation (3). 
Additionally, chemotherapy may com-
promise the normal barrier function 
provided by the skin—a compromise 
that is manifest clinically as oral and 
Implication for Patient Care
 n MR imaging can be used success-
fully to depict perianal inflamma-
tion, abscesses, and fistulas in 
patients with hematologic malig-
nancies and perianal symptoms 
and to distinguish such patients 
from immunocompetent 
individuals.
Advances in Knowledge
 n Patients with hematologic malig-
nancies and perianal symptoms 
had considerably greater perianal 
edema than did immunocompe-
tent patients with cryptoglandu-
lar disease (58.7% vs 13.4% of 
anal canal height inflamed).
 n Perianal fistulas were less 
common in patients with hema-
tologic malignancies with peri-
anal symptoms (21 [55.3%] of 
38) than in immunocompetent 
patients (35 [92.1%] of 38).
 n Patients with hematologic malig-
nancies and perianal symptoms 
formed perianal and pelvic ab-
scesses in 26.3% of cases (10 of 
38), even in the presence of 
neutropenia.
 n Acute surgical treatment was 
required in only approximately 
10% of patients (four of 38) with 
hematologic malignancies and 
perianal symptoms.
 n MR imaging can help discrimi-
nate between the appearance of 
perianal infection in patients 
with hematologic malignancies 
and that in immunocompetent 
patients in most cases (areas 
under the receiver operating 
characteristic curve, 0.91 and 
0.97).
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perianal mucositis, which predisposes 
to infection (4).
Perianal infection occurs in approx-
imately 5%–10% of patients with acute 
leukemia (5–8) and may occasionally 
be the presenting complaint (9). The 
underlying pathophysiology is believed 
to be no different from that in immu-
nocompetent patients—that is, infec-
tion begins in the intersphincteric anal 
glands (10). However, the clinical man-
ifestation may be modified by immuno-
compromise and impaired pus forma-
tion due to neutropenia. This results in 
diffuse perianal swelling, edema, and 
erythema rather than the more typical 
fluctuant collection (11). Although clini-
cally obvious abscesses require prompt 
drainage to prevent systemic sepsis or 
even death (6), clinicians may be reluc-
tant to examine the anus and rectum 
of immunocompromised patients for 
fear of provoking bacteremia and dete-
rioration. Indeed, consensus guidelines 
prohibit digital rectal examination of 
patients with neutropenia (12). This 
causes a diagnostic dilemma: Occult 
infection requires prompt identifica-
tion and treatment, particularly with 
an attenuated host immune response, 
but detailed physical examination is rel-
atively contraindicated. Magnetic reso-
nance (MR) imaging can help resolve 
this by demonstrating the presence, 
extent, and distribution of perianal sep-
sis, allowing surgical intervention to be 
appropriately planned (13).
Here, we test the hypotheses that 
(a) perianal abscess formation is less 
common in patients with hematologic 
malignancies than in immunocompe-
tent individuals and (b) that diffuse 
perianal edema is more common. We 
aimed to use MR imaging to document 
the distribution and morphology of 
perianal disease in patients with hema-
tologic malignancies and in immuno-
competent control patients.
Materials and Methods
Ethical permission and patient consent 
are not required by our institution for 
retrospective review of imaging series 
acquired during normal patient care.
Patient Selection
Using the hospital radiology informa-
tion system, we identified patients who 
had undergone anorectal MR imaging 
between January 2007 and March 2014 
(inclusive) after being referred by a he-
mato-oncologist. Patients were included 
if they had been given a diagnosis of he-
matologic malignancy according to their 
electronic patient record and if they 
were imaged for the evaluation of peri-
anal symptoms and/or systemic sepsis. 
Exclusion criteria were a diagnosis of 
Crohn disease or nonhematologic ma-
lignancy or previous anorectal surgery. 
Thirty-eight patients with hematologic 
malignancies underwent 50 MR imag-
ing examinations during the study pe-
riod. Because we expected repeat ex-
aminations in the same patient to be 
more similar than those from different 
individuals (ie, clustered), only the ear-
liest MR imaging study was used for ini-
tial analysis. However, we subsequently 
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Table 1
MR Imaging Parameters
Parameter
1.5-T Imaging Units 3.0-T Imaging Units
Coronal/Axial STIR Sequence
Sagittal/Axial T2-weighted  
TSE Sequence Coronal/Axial STIR Sequence
Sagittal/Axial T2-weighted  
TSE Sequence
Field of view (cm) 18–24 18–24 18–24 18–24
No. of sections 25/40 25/40 25/35 25/35
Repetition time (msec) 3470/5650 4910/8370 4400/5075 3890/5075
Echo time (msec) 21/30 97/99 60/60 100/85
Inversion time (msec) 150/150 NA 200/200 NA
Echo train length 7/7 13/15 12/12 20/17
Image matrix 256 3 159/256 3 173 256 3 256/256 3 173 244 3 192/244 3 192 256 3 244/348 3 205
Section thickness (mm) 4/4 6/4 3/3 3/3
Section gap (mm) 5/4.4 6/4.4 4/4 4/3.3
No. of signals acquired 1/1 3/3 2/2 3/2
Note.—NA = not applicable, TSE = turbo spin echo.
inspected follow-up MR imaging stud-
ies to determine if imaging features 
changed over time.
For each patient, we chose a control 
patient, defined as the next sex- and 
age-matched patient (to within 5 years) 
who underwent imaging after the study 
patient. Control patients had been im-
aged for perianal symptoms and/or 
systemic sepsis but had no preceding 
diagnosis of malignancy, immunocom-
promise, or Crohn disease according to 
their electronic patient record. Control 
patients were followed up for a median 
of 4.3 years (interquartile range: 2.1–
5.8 years; range, 1.6–7.5 years) to con-
firm that these diseases did not develop 
subsequently.
Clinical Data Recorded
For patients with hematologic malig-
nancies we recorded the following: 
(a) age and sex; (b) the hematologic 
diagnosis; (c) current or recent (,3 
months) use of chemotherapy; (d) any 
previous bone marrow transplantation 
and, if relevant, its type; (e) the lowest 
neutrophil count at the time of imag-
ing (within 2 weeks of the examina-
tion date); (f) perianal symptoms; (g) 
requirement for immediate (1 week) 
surgical drainage; and (h) any subse-
quent need for re-drainage, examina-
tion under anesthesia, or specific treat-
ment for perianal fistula. For control 
patients, we recorded a and f–h from 
the above list.
Imaging Protocol and Viewing Conditions
All patients were imaged with one of 
five MR imaging units: three units with 
a 1.5-T field strength (Avanto or Sym-
phony; Siemens, Erlangen, Germany) 
and two with a 3.0-T field strength 
(Ingenia or Achieva, Philips, Best, the 
Netherlands). Imaging protocols com-
prised sagittal and axial oblique T2-
weighted turbo spin-echo sequences, 
as well as axial oblique and coronal 
oblique short inversion time inversion 
recovery (STIR) imaging, angled to the 
central axis of the anal canal (Table 1).
Images were viewed independently 
in a random order with a picture ar-
chiving and communication system 
(Impax 6.4.0.4551; Agfa Healthcare, 
Mortsel, Belgium) by two abdominal 
radiologists (A.A.P. [radiologist 1] and 
G.B. [radiologist 2], with 7 and 6 years 
of experience in abdominopelvic MR 
imaging, respectively). Randomization 
was performed separately for each ra-
diologist by using statistical software 
(14). Although the radiologists were 
aware that they would be interpreting 
findings in patients with and patients 
without hematologic malignancies and 
that there was a clinical suspicion of 
perianal sepsis, they were blinded to 
clinical information and results of prior 
imaging examinations. They were asked 
to record the presence of the following: 
(a) discrete fluid collections or ab-
scesses and their number, size, and 
location; (b) any internal enteric open-
ing in the anal canal; (c) fistulous or 
sinus tracts and their type (according 
to classification system of Parks et al 
[15]); and (d) any extensions from this 
primary tract, including their location. 
An abscess was defined as a localized, 
rounded collection of predominantly 
fluid signal intensity that exhibited a 
mass effect on adjacent structures, and 
a fistula was defined as an elongated 
tubular structure with an internal en-
teric and external opening. The anal 
canal was defined as that part of the 
gastrointestinal tract running between 
the anorectal junction at the level of 
the puborectalis sling and the external 
anal margin. Each radiologist made the 
assessment separately, and disagree-
ments were subsequently resolved in 
consensus. The radiologists also esti-
mated the proportion of the anal canal 
and the perianal region that exhibited 
MR imaging features of inflammation, 
defined as high signal intensity distinct 
from that of normal blood vessels on 
STIR images (16). This assessment 
was made by using (a) the axial section 
judged to be most abnormal, with ex-
tent described as the number of hours 
of an imaginary clock face centered on 
150 radiology.rsna.org n Radiology: Volume 276: Number 1—July 2015
GASTROINTESTINAL IMAGING: MR Imaging Appearances of Perianal Sepsis in Patients with Hematologic Malignancy Plumb et al
the anal canal, and (b) the coronal sec-
tion judged to be most abnormal, with 
extent described as the percentage of 
the length of the anal canal that ap-
peared inflamed. Finally, the radiolo-
gists were asked to classify the patient 
as having a hematologic malignancy or 
not by using a 101-point scale. They 
were informed that existing clinical lit-
erature suggested that diffuse perianal 
inflammation was common in immuno-
compromised patients (11), but they 
were not required to use specific MR 
imaging criteria—instead, they were 
asked to give their overall clinical opin-
ion. A score of 100 was assigned when 
the radiologists were certain of the 
diagnosis of hematologic malignancy; 
scores of 50 or greater were used to 
indicate preference for that diagnosis. 
A score of 0 indicated certainty that 
the patient was an immunocompetent 
control patient; scores of less than 50 
were used when this was believed to be 
more likely.
Statistical Analysis
Data were collated by using Excel 
for Macintosh (Microsoft, Redmond, 
Wash) and were analyzed by using R, 
version 2.15.1 (R Foundation for Sta-
tistical Computing, Vienna, Austria). 
Between-group comparisons were per-
formed by using the Mann-Whitney-
Wilcoxon test. To determine which MR 
imaging features were more commonly 
seen in immunocompetent control pa-
tients and which predominated in pa-
tients with hematologic malignancies, 
we compared the proportion of patients 
in each group using the x2 test (or the 
Fisher exact test where expected cell 
counts were  5), considering P , .05 
to indicate a significant difference. We 
used the consensus interpretation of 
the two radiologists to define the true 
presence or absence of a particular MR 
imaging feature. Agreement between 
radiologists was assessed by means of 
percentage agreement for binary var-
iables and by means of Bland-Altman 
limits of agreement for quantitative 
variables (17). To determine the ability 
of MR imaging to help distinguish pa-
tients with hematologic malignancies 
from control patients, we constructed 
receiver operating characteristic (ROC) 
curves for each reader using their in-
dividual confidence scores (18). Em-
piric curve thresholds were taken above 
and below each confidence score, and 
smoothed curves used the binormal as-
sumption. Areas under the ROC curve 
(AUCs) were calculated by using the 
trapezoidal method; 95% confidence 
intervals (CIs) for empiric AUCs were 
constructed according to the method of 
DeLong et al (19), and smoothed AUCs 
were calculated with the percentile 
method from 2000 bootstrap replicates.
Results
Clinical Characteristics
Patient demographics and clinical fea-
tures are shown in Table 2. Men out-
numbered women at a rate of approx-
imately two to one. The mean age was 
38.9 years in the study group and 41.5 
years in the control group. Neutrophil 
counts were available for 37 of 38 pa-
tients with hematologic malignancies: 
28 (75.7%) had neutrophil counts of 
less than 1.0 3 109/L, indicating mod-
erate neutropenia, and 24 (64.9%) 
were severely neutropenic (neutrophil 
count, ,0.5 3 109/L) (20). Only one 
patient had a normal neutrophil count 
(.2.5 3 109/L). Seven (18.4%) of the 
38 patients had previously undergone 
bone marrow transplantation (five allo-
grafts and two autografts). Twenty-six 
(68.4%) of the patients were undergo-
ing chemotherapy at the time of the MR 
imaging examination, and 33 (86.8%) 
had undergone chemotherapy within 3 
months.
The most common symptom pro-
voking MR imaging was pain, in both 
the study group (34 [89.5%] of 38) 
and the control patients (28 [73.7%] of 
Table 2
Demographic Data, Clinical Features, and Subsequent Treatment for Patients with 
Hematologic Malignancy and Matched Control Patients
Parameter
Patients with Hematologic  
Malignancy (n = 38) Control Patients (n = 38) P Value
Baseline parameters
 Age (y)* 38.9 6 18.5 41.5 6 14.7 .41
 No. of men 25 (65.8) 25 (65.8) ..99
 Neutrophil count (×109/L)* 1.09 6 1.92 ... ...
Hematologic diagnosis
 Acute myeloid leukemia 21 (55.3) ... ...
 Acute lymphoid leukemia 3 (7.9) ... ...
 B-cell lymphoma 3 (7.9) ... ...
 Other 11 (28.9) ... ...
Clinical features
 Pain 34 (89.5) 28 (73.7) .14
 Fever 18 (47.4) 8 (21.1) .03
 Discharge 5 (13.2) 19 (50.0) .001
 Swelling 6 (15.8) 6 (15.8) ..99
Subsequent treatment
 Incision and drainage 4 (10.5) 8 (21.1) .34
 Examination under anesthesia 6 (15.8) 34 (89.5) ,.001
 Seton 1 (2.6) 18 (47.4) ,.001
 Other fistula treatment 2 (5.3) 15 (39.5) ,.001
  Lay-open procedure 2 (5.3) 10 (26.3) .03
  Fistula plug 0 3 (7.9) .24
  Advancement flap 0 2 (5.3) .47
Note.—Unless otherwise specified, data are numbers of patients, with percentages in parentheses.
* Data are means 6 standard deviations.
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Figure 1
Figure 1: Axial STIR MR image (repetition 
time msec/echo time msec/inversion time msec, 
5650/30/150) through the anal canal in a 57-year-
old man with mantle cell lymphoma shows an 
intersphincteric abscess (arrow).
Table 3
MR Imaging Findings in Patients with Hematologic Malignancy and Control Patients
Finding
Patients with Hematologic  
Malignancy (n = 38)
Control Patients  
(n = 38) P Value
Abscess
 No. of patients with an abscess 10 (26.3) 17 (44.7) .15
 Location of abscess*
  Intersphincteric 9 (23.7) 10 (26.3) ..99
  Ischioanal 1 (2.6) 7 (18.4) .18
  Supralevator 1 (2.6) 1 (2.6) ..99
  Subcutaneous 1 (2.6) 0 ..99
 Mean diameter of abscess (cm) 2.0 2.1 .69
Fistula tracts
 No. of patients with a visible internal  
  opening
21 (55.3) 35 (92.1) ,.001
 No. of patients with a fistula 15 (39.5) 35 (92.1) ,.001
 No. of patients with a fistula who  
  also had extensions
4 (26.7) 11 (31.4) ..99
Classification of primary fistula
 Intersphincteric 12 (80.0) 20 (57.1) .22
 Transsphincteric 3 (20.0) 15 (42.9) ...
Perianal inflammation
 Mean no. of hours of the clock  
  involved (axial)
7.2 1.9 ,.001
 Mean percentage of the anal canal  
  height involved (craniocaudal)
58.7 13.4 ,.001
Radiologist 1 diagnosis
 Correct 27 37 ...
 Incorrect 11 1 ...
Radiologist 2 diagnosis
 Correct 25 38 ...
 Incorrect 13 0 ...
Note.—Unless otherwise specified, data are numbers of patients, with percentages in parentheses.
* One patient with hematologic malignancy and two control patients had abscesses in more than one anatomic compartment.
38). Fever was more common among 
patients with hematologic malignancies 
(18 [47.4%] of 38) than among control 
patients (eight [21.1%] of 38; P = .03), 
whereas control patients were more 
likely to have discharge (five patients 
[13.2%]; 19 control patients [50.0%]; 
P = .001).
MR Imaging Features
MR imaging appearances in patients 
with hematologic malignancies and con-
trol patients are summarized in Table 3. 
There was good agreement between the 
two radiologists regarding the presence 
of abscess (agreement in 71 [93.4%] 
of the 76 total patients) and fistula 
(agreement in 62 [81.6%] of the 76 to-
tal patients). At subsequent consensus 
interpretation, patients with hemato-
logic malignancies were observed to 
have a lower rate of abscess formation 
(10 [26.3%] of 38) than did control pa-
tients (17 [44.7%] of 38), but this dif-
ference was not statistically significant 
(P = .15). There was no difference in 
the average size of abscesses when pre-
sent (patients with hematologic malig-
nancies: 2.0 cm; control patients: 2.1 
cm; P = .69). There was no discernible 
relationship between neutrophil count 
and the presence of abscesses in pa-
tients with hematologic malignancies 
(patients without an abscess, median 
neutrophil count = 0.49 3 109/L [inter-
quartile range, 0.07–1.09 3 109/L]; pa-
tients with an abscess, median neutro-
phil count = 0.44 3 109/L [interquartile 
range, 0.08–0.69 3 109/L]; P = .71). 
Similarly, there was no significant dif-
ference in rates of abscess formation 
between patients who had and those 
who had not undergone bone marrow 
transplantation (two [28.6%] of seven 
patients who had undergone trans-
plantation had an abscess, while eight 
[25.8%] of 31 patients who had not 
undergone transplantation had an ab-
scess; P > .99) or between patients who 
had and those who had not recently 
(,3 months) received chemotherapy 
(recent chemotherapy: seven [21.2%] 
of 33 patients had an abscess; no re-
cent chemotherapy: three [60.0%] of 
five had an abscess; P = .10, Fig 1).
Fistulas were less common in pa-
tients with hematologic malignancies 
than in control patients, occurring in 
15 (39.5%) of 38 such patients versus 
35 (92.1%) of 38 control patients (P , 
.001). An internal opening was visible 
for 21 (55.3%) patients with hemato-
logic malignancies and 35 (92.1%) con-
trol patients (P , .001). Considering 
152 radiology.rsna.org n Radiology: Volume 276: Number 1—July 2015
GASTROINTESTINAL IMAGING: MR Imaging Appearances of Perianal Sepsis in Patients with Hematologic Malignancy Plumb et al
Figure 2
Figure 2: (a, b) Axial STIR MR images (5650/30/150) through the anal canal in (a) a 51-year-old man 
with acute myeloid leukemia who was scored as having circumferential edema of the anal canal (ie, edema 
in all 12 hours of an imaginary clock face) by both radiologists and (b) the corresponding control patient, a 
49-year-old man who was scored as having inflammation (small arrows) over 2 hours of the clock face by 
both radiologists. Large arrow = fistula tract.
only those individuals with a fistula, 
the proportion of individuals with ex-
tensions from the primary tract did not 
differ between patients with hemato-
logic malignancies and control patients 
(four [26.7%] of 15 vs 11 [31.4%] of 
35; P > .99). Intersphincteric fistulas 
were the most common fistula type in 
both groups (patients with hemato-
logic malignancies: 12 [80.0%] of 15; 
control patients: 20 [57.1%] of 35; P 
= .22). A single patient with a hema-
tologic malignancy subsequently was 
observed to have developed an inter-
sphincteric fistula at follow-up MR im-
aging (performed 4 months after the 
index examination). No other fistulas 
were observed to have developed in the 
follow-up MR imaging studies.
The amount of abnormal perianal 
MR imaging signal intensity on the STIR 
images was considerably greater for 
patients with hematologic malignancies 
than for control patients (Fig 2; Figs 
E1, E2 [online]). The mean number of 
hours of the clock face showing high sig-
nal intensity on STIR images was 7.2 for 
patients with hematologic malignancies 
(approximately a 220° arc angle), ver-
sus 1.9 for control patients (approx-
imately a 60° arc angle, P , .001). 
Similarly, a longer segment of the anal 
canal was inflamed in patients with he-
matologic malignancies (mean, 58.7% 
length inflamed) than in control patients 
(mean, 13.4% inflamed; P , .001). 
There was good agreement between 
the two radiologists when estimating 
the amount of abnormal high signal 
intensity on STIR images for both the 
clock face estimate (mean difference, 
0.039 hours of a clock [1.2° arc angle]; 
Bland-Altman limits of agreement, 3.3 
hours of a clock [98.1°]; Fig 3a) and 
the percentage length of anal canal in-
volvement (mean difference, 20.59%; 
Bland-Altman limits of agreement, 
27.3%; Fig 3b).
Radiologist 1 classified 37 (97.4%) 
of 38 control patients correctly (ie, as-
signed a confidence score of , 50), 
whereas radiologist 2 classified all con-
trol patients correctly. The single con-
trol patient believed to have a hemato-
logic malignancy by radiologist 1 had a 
1.8-cm intersphincteric collection and 
diffuse anal edema. Patients with hema-
tologic malignancies were categorized 
correctly in 27 (71.1%) of 38 cases 
by radiologist 1 and in 25 (65.8%) of 
38 cases by radiologist 2. The overall 
ability of MR imaging to help discrim-
inate patients with hematologic ma-
lignancies from control patients was 
good: AUCs were 0.97 (95% CI: 0.93, 
1.00) for the empiric curve and 0.97 
(95% CI: 0.90, 0.98) for the smoothed 
curve for radiologist 1 and 0.90 (95% 
CI: 0.83, 0.98) for the empiric curve 
and 0.91 (95% CI: 0.81, 0.97) for the 
smoothed curve for radiologist 2 (Fig 4). 
The sensitivity, specificity, positive pre-
dictive value, and negative predictive 
value for hematologic malignancies, 
respectively, were 71.1%, 97.4%, 
96.4%, and 77.1% for radiologist 1 
and 65.8%, 100%, 100%, and 74.5% 
for radiologist 2. A total of 16 patients 
with hematologic malignancies were 
incorrectly categorized as immunocom-
petent control patients by at least one 
radiologist. Incorrectly categorized pa-
tients were more likely to have a fistula 
(incorrect: 10 [62.5%] of 16 had a fis-
tula; correct: five [22.7%] of 22 had a 
fistula; P = .032) and had significantly 
less edema than correctly categorized 
patients (mean height inflamed for in-
correctly categorized patients, 35.8% 
of anal canal; mean height inflamed for 
correctly categorized patients, 81.6%; 
P , .001).
Subsequent Treatment
Overall, requirement for acute inci-
sion and drainage of an abscess did 
not differ significantly between the two 
groups (patients with hematologic ma-
lignancies: four [10.5%] of 38; control 
patients: eight [21.1%] of 38; P = .35). 
However, subsequent performance 
of examination under anesthesia was 
significantly less frequent for patients 
with hematologic malignancies (six 
[15.8%] of 38) than control patients 
(34 [89.5%] of 38, P , .001). Only a 
single patient (2.6%) with a hemato-
logic malignancy required a seton (ie, 
insertion of a suture along the fistula 
tract to encourage drainage of pus), 
whereas 18 control patients (47.4%) 
did (P , .001). Only two (5.3%) of 
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Figure 4
Figure 4: A, B, Empiric (solid line) and smoothed (dashed line) ROC curves for the distinction of patients 
with hematologic malignancies from control patients for, A, radiologist 1 and, B, radiologist 2. Shaded area = 
95% CIs around the summary curve.
Figure 3
Figure 3: (a, b) Bland-Altman plots show agreement between the two radiologists in the assessment of (a) radial inflammation of the anal canal (measured in 
hours of an imaginary clock face) and (b) the height of anal canal inflammation (percentage height of anal canal inflamed). Solid line = mean difference, dashed lines 
= 95% limits of agreement.
38 patients with hematologic malig-
nancies had a fistula tract laid open, 
versus 10 (26.3%) of 38 control pa-
tients (P = .025). Additionally, three 
control patients underwent placement 
of a fistula plug, and two required an 
advancement flap (subsequently re-
peated for recurrence in one case). No 
patient with a hematologic malignancy 
died within 4 weeks of their MR im-
aging examination—that is, the lack of 
surgical treatment was not due simply 
to patient death.
Discussion
More than 135 000 patients are given 
a diagnosis of a hematologic malig-
nancy each year in the United States 
(21). Although intensive chemother-
apy regimens (often supplemented by 
bone marrow transplantation) are fre-
quently curative, the resulting immu-
nocompromise may be profound, and 
serious infections commonly occur. 
Perianal sepsis occurs in 5%–10% of 
patients with hematologic malignancies 
and causes substantial morbidity and, 
occasionally, death (8). MR imaging 
is well established as a valuable tech-
nique for assessing perianal infection 
in patients with cryptoglandular infec-
tion and Crohn disease, and surpasses 
surgical examination under anesthe-
sia because it reveals sites of infec-
tion that are clinically occult (13,16). 
Because of this, we anticipated that 
the utility of MR imaging would be 
similarly high in patients with hemato-
logic malignancies.
We found that, contrary to our ex-
pectation, perianal abscesses were rel-
atively common in patients with hema-
tologic malignancies, including those 
with neutropenia. Although the ability 
to form pus is impaired by neutropenia 
(22), our data suggest that this is not 
absolute—we found no significant dif-
ference in rates of abscess formation 
between patients with hematologic 
malignancies and control patients, and 
no effect of the degree of neutropenia 
on the frequency of abscess formation. 
The size and location of abscesses 
was also no different between the two 
groups, supporting the hypothesis that 
the underlying pathophysiology (cryp-
toglandular sepsis) is the same in the 
two groups. Importantly, the MR im-
aging finding of an abscess does not 
exclude hematologic malignancy as an 
underlying etiology.
Reports describing findings of clin-
ical examination have suggested that 
diffuse edema and induration are com-
mon manifestations of perianal disease 
in hematologic malignancies (11). Sup-
porting this, using imaging, we found 
a significantly greater degree of abnor-
mal perianal high signal intensity on 
STIR images at MR imaging in patients 
with hematologic malignancies. On av-
erage, more than half of the anal canal 
showed abnormal high signal intensity 
on STIR images (approximately 60% 
of both height and radial extent), in 
comparison to approximately 10%–
15% for control patients. The reason 
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for this difference is unclear, but the 
two main possibilities are either alter-
ations in the host immune response 
or, alternatively, different micro-or-
ganisms opportunistically infecting 
the immunocompromised host and 
causing a different clinical phenotype. 
The former seems more likely, as re-
sults in microbiologic series (5,6,8,23) 
suggest that the pathogens isolated 
from patients with hematologic ma-
lignancies are gut commensals such 
as Enterobacteriaceae—no different 
from those in immunocompetent pa-
tients. Irrespective of the precise rea-
son, MR imaging appearances clearly 
differ in patients with hematologic 
malignancies from those in control 
patients, and these imaging features 
do not mandate surgical intervention. 
This corroborates historical surgical 
series (23), in which 55%–88% of 
cases of perianal infection in patients 
with hematologic malignancies were 
controlled by antibiotics alone. In our 
study, a subset of patients with hema-
tologic malignancies were erroneously 
believed to be immunocompetent con-
trol patients at MR imaging. Such pa-
tients had a simple, noninflamed fis-
tula tract, causing the appearances to 
be similar to those in immunocompe-
tent individuals.
We found that defined fistula tracts 
were less common in patients with he-
matologic malignancies (21 of [55.3%] 
of 38 patients) than in control patients 
(35 [92.1%] of 38 patients). Accord-
ingly, the rate of performance of ex-
amination under anesthesia, seton 
placement, or other fistula treatment 
was lower in patients with hematologic 
malignancies. We propose that recov-
ery from the nadir of neutropenia (eg, 
after cessation of chemotherapy) al-
lows perianal healing without the need 
for subsequent treatment, explaining 
the lower rates of fistula. Conversely, 
control patients developing perianal 
sepsis have already developed chronic 
infection that is beyond the immune 
system’s ability to control and cannot 
escalate the host response any further. 
An alternative possibility is that pa-
tients with hematologic malignancies 
were imaged with less severe disease 
than control patients, meaning that 
prompt treatment prevented fistula-
tion. This seems unlikely, because we 
found no difference in the rate of ab-
scess formation, and the inflammatory 
reaction (as judged by the extent of sig-
nal intensity change on STIR images) 
was greater, implying a more severe 
initial disease process.
Our study had limitations. First, 
our cohort was retrospective, although 
sizeable for a relatively uncommon 
group. We treated all patients with 
hematologic malignancies as a single 
group, whereas in reality, there may 
be differences in immune function be-
tween patients with different subtypes 
of hematologic malignancies undergo-
ing various treatments. The study was 
conducted in a Western hemisphere 
tertiary oncology center: Results may 
not generalize more widely. All MR 
imaging studies were interpreted by 
one of two experienced radiologists, 
which may also limit generalizability 
to more general radiologists. We did 
not administer intravenous contrast 
medium, which may have reduced our 
ability to detect abscesses; however, 
because the MR imaging protocol was 
the same for both patient groups, this 
should not affect our overall conclu-
sions. Nonetheless, it is possible that 
the absolute prevalence of abscesses 
in both immunocompetent patients 
and patients with hematologic malig-
nancies was higher than what we re-
port here.
In summary, patients with hema-
tologic malignancies undergoing MR 
imaging for perianal symptoms have 
considerably greater local inflammatory 
signal change than immunocompetent 
patients with perianal sepsis. Fistula 
tracts are significantly less common in 
patients with hematologic malignancies, 
although rates of abscess formation 
are not significantly different. Perianal 
disease in patients with hematologic 
malignancies rarely required surgical 
treatment, either at the time of imag-
ing or thereafter. Radiologists should 
recognize the potential for hematologic 
malignancies and associated neutrope-
nia to alter the typical MR imaging fea-
tures of perianal infection.
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